| Bioactivity | Ro 43-5054 is a platelet glycoprotein IIb-IIIa receptor antagonist. Ro 43-5054 can be used in the research of early reocclusion after thrombolytic therapy[1]. |
| CAS | 138107-58-1 |
| Formula | C24H27N5O7 |
| Molar Mass | 497.50 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. S P Roux, et al. Effects of heparin, aspirin and a synthetic platelet glycoprotein IIb-IIIa receptor antagonist (Ro 43-5054) on coronary artery reperfusion and reocclusion after thrombolysis with tissue-type plasminogen activator in the dog. J Pharmacol Exp Ther. 1993 Jan;264(1):501-8. |
Ro 43-5054
CAS: 138107-58-1 F: C24H27N5O7 W: 497.50
Ro 43-5054 is a platelet glycoprotein IIb-IIIa receptor antagonist. Ro 43-5054 can be used in the research of early reoc
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.